Skip to content Provide accessibility feedback
By using the Volpara website you accept our use of cookies. Here’s our privacy statement.
Breast Health
Lung Health
Magnifying glass Search

Ambry Genetics

Ambry Genetics®, as part of Konica Minolta Precision Medicine, excels at translating scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind the genetic disease.



Fujifilm uses a wealth of experience to enable high-precision and high-resolution mammography.

Fuji-logo_website (002)

GE Healthcare

A personalized approach to breast care.  Every woman deserves breast care customized to her personal risk factors. GE Healthcare’s personalized breast care portfolio provides  clinicians the tools to provide advanced, personalized care to help achieve the best outcomes.



iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. They work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.

iCAD logo resize (1)

MeVis Medical Solutions AG

Veolity™ is a dedicated software package for lung cancer diagnostics optimized for low dose CT lung cancer screening. Veolity includes automated AI-enabled nodule detection, automatic segmentation, temporal comparison, and optimized workflow for structured reporting. Veolity is manufactured by MeVis Medical Solutions AG.


Myriad Genetics

Myriad Genetics is a leading molecular diagnostic company dedicated to saving and improving lives by discovering and delivering tests across major diseases.



Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do this by delivering the most advanced, radiomics and AI-enabled, lung cancer decision support software, driving the optimal clinical pathway for each patient.

Group 1 (1)

ScreenPoint Medical

ScreenPoint Medical is the leading developer of AI-driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations. With proven accuracy at least matching that of experienced radiologists, ScreenPoint’s Transpara™ system is the most advanced available, exploiting big data, deep learning and the latest advances in artificial intelligence. The system can identify high-risk breast lesions quickly, enabling earlier detection, earlier treatment and a greater chance of survival.


Interested in collaborating with Volpara?

Contact our business development team.